Korea Arlico Pharm Co.,Ltd.

₩1,782As of Sun 8 Nov 2026, 12:00 UTC
KOSDAQ:260660Healthcare
Country South Korea
PE (Fwd) •••
TSR 9Y CAGR (20.30%)
Div yield 4.21%
ROE (3.67%)
Pharmaceutical Preparations
Beta (5Y) 0.37
PE TTM —
TSR TTM (51.67%)
Mkt cap ₩27.31B
ROIC (8.17%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩2,204
23.68%
91.56%
Hold 12|7|3|2|8
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
18.66
18.86
18.97
19.66
(1.31%)
4.08%
(0.74%)
3.16%
Revenue₩B
1.757
1.707
1.692
1.729
12.99%
6.08%
3.43%
3.22%
Peers (US$20.14M)
Cap (US$)
PE
19.32M
8.765x
Capital
TTM
5Y
10Y
Leveragex
2.969
(0.143)
(0.111)
EBIT/Intx
5.118
4.901
4.899
Own earn%
15.85
62.33
55.65
Sh yield%
38.98
28.98
25.03
Owners
Insiders/Inst%
8.25
66.73
Short interest%
5.80
SBC / revenue%
2.97
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
6
Op margin range%
28–34
$1 testx
0.0
Incr. ROIC%
1